Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06902584 · ClinicalTrials.gov registry record
North American Comfilcon A Clinical Study
A clinical trial of Presbyopia and Astigmatism, sponsored by CooperVision International Limited (CVIL).
- Recruiting
- Registry status
- 182
- Enrollment target
- 4
- Study locations
NCT06902584: Recruiting study of Presbyopia and Astigmatism, sponsored by CooperVision International Limited (CVIL).
NCT06902584 is a study of Presbyopia and Astigmatism that is actively recruiting participants, run by CooperVision International Limited (CVIL). The registered enrollment target is 182 participants, below the 266-participant average among 38 other Presbyopia trials with a reported enrollment target (32% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06902584, a study of Presbyopia and Astigmatism, is actively recruiting participants, sponsored by CooperVision International Limited (CVIL).
- RECRUITING
- Registry status
- 182 participants
- Enrollment target
- 4
- Study locations
Study Summary
The main objective of this study is to demonstrate acceptable safety and effectiveness (performance) of comfilcon A Sphere, Toric, Multifocal, Toric Multifocal and Energys lenses, when used in the general population.
Primary Outcome
Visual Performance will be measured using logMAR * High contrast, high illumination distance VA * High contrast, high illumination near VA
Conditions Studied
Interventions
- DEVICE comfilcon A Sphere lens
- DEVICE comfilcon A Toric lens
- DEVICE comfilcon A Multifocal lens
- DEVICE comfilcon A Multifocal Toric lens
- DEVICE comfilcon A Energys lens
Study Locations (4)
California
- University of Berkeley - Berkeley
Ohio
- ProCare Vision Center - Granville
Pennsylvania
- Nittany Eye Associates - College
Texas
- Drs. McIntyre, Garza, Avila and Jurica, Optometrists - Corpus Christi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2025-02-05 |
| Est. Completion | 2025-12 |
What NCT06902584 shows while recruiting
NCT06902584 is an observational study that tracks outcomes without assigning an intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, below the 266-participant average among 38 other Presbyopia trials with a reported enrollment target (32% lower).
The record links to 3 conditions, with Presbyopia appearing as the primary indexed condition, and to 5 interventions - of which comfilcon A Sphere lens is the first listed.
NCT06902584 reports a single indexed study location in California, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06902584 about?
NCT06902584 is a clinical study titled "North American Comfilcon A Clinical Study". The main objective of this study is to demonstrate acceptable safety and effectiveness (performance) of comfilcon A Sphere, Toric, Multifocal, Toric Multifocal and Energys lenses, when used in the general population.
What is the current status of trial NCT06902584?
This trial is currently recruiting. The enrollment target is 182 participants. The study started on 2025-02-05. Estimated completion is 2025-12.
What conditions does trial NCT06902584 study?
This clinical trial studies the following conditions: Presbyopia, Astigmatism, Ametropia.
What interventions are being tested in trial NCT06902584?
The interventions under investigation include: comfilcon A Sphere lens (DEVICE), comfilcon A Toric lens (DEVICE), comfilcon A Multifocal lens (DEVICE), comfilcon A Multifocal Toric lens (DEVICE), comfilcon A Energys lens (DEVICE).
Who is sponsoring clinical trial NCT06902584?
This trial is sponsored by CooperVision International Limited (CVIL), which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06902584 being conducted?
This trial has 4 study locations across California, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06902584's enrollment target sits among peer trials
182 11th of 38 higher than 28 of 38 other Presbyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Presbyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Comfort and Vision With TOTAL30 Multifocal Lenses
RECRUITING
-
IC-8 Apthera IOL New Enrollment Post Approval Study
RECRUITING
-
Quality of Life in Presbyopic Patients Who Are Treated With Qlosi
RECRUITING · Phase 4
-
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI